Journal
NEUROPHARMACOLOGY
Volume 48, Issue 3, Pages 381-390Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2004.10.011
Keywords
oscillations; in vitro; network; cholinergic; 5-HT1A; 5-HT2; electrophysiology
Categories
Ask authors/readers for more resources
Fast rhythmic activity in a frequency range between 20 and 40 Hz occurs in vitro in hippocampal area CA3 after activation of muscarinic receptors. Here we show that carbachol-induced rhythmic activity is modulated by serotonin (5-HT). Spectral analysis reveals that 5-HT (0.3-30 mu M) decreases power, but not frequency, of rhythmic activity in a concentration-dependent and reversible manner. The 5-HT1A agonists 8-OH-DPAT and buspirone mimic the effect of 5-HT, whereas the selective 5-HT1A receptor antagonist WAY-100635 (1 mu M) significantly prevents the effect of 5-HT1A. In contrast to the effect of 5-HT1A agonists, the 5-HT2 agonist DOI increases spectral power and prevents the reduction of spectral power by 5-HT. Application of WAY-100635 alone has no effect on rhythmic activity. Likewise, the 5-HT2 antagonist ritanserin (10 mu M) does not affect rhythmic activity, or its reduction by 5-HT. Finally, the 5-HT re-uptake inhibitor fluoxetine significantly decreases rhythmic activity in the presence of a low concentration of 5-HT, suggesting that 5-HT released from terminals in the slice likely reduces rhythmic activity. These results strongly implicate 5-HT1A and 5-HT2 receptors in the modulation of spectral power of carbachol-induced rhythmic activity and that 5-HT1A receptors are responsible for the prevailing effect of 5-HT. (c) 2004 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available